Our Centres
Our Doctors
Your state: SA |
Our Centres
Our Doctors
Dr Hendrick Tan
MBBS, FRANZCR, Radiation Oncologist
For patients/carers
For doctors
MBBS, FRANZCR, Radiation Oncologist
Locations
Clinical interests
- Neuro-oncology
- Lung cancer
- Genitourinary cancer
- Gastrointestinal cancer
- Oligometastatic disease
- Skin cancer
Treatment techniques
- Stereotactic body radiotherapy (SBRT) / Stereotactic ablative radiotherapy (SABR)
- Stereotactic radiosurgery (SRS)
- Magnetic Resonance Image-Guided Radiotherapy (MRIgRT)
Languages
Fluent
- English
- Mandarin / 官话
- Malay / Melayu
Biography
Clinical interests include neuro-oncology, thoracic malignancies, oligometastatic disease, and gastrointestinal, urological, and skin cancers. Treatment techniques include stereotactic ablative body radiotherapy (SABR), stereotactic radiosurgery (SRS), and MRI-guided adaptive radiotherapy (MRIgRT).
Dr Hendrick Tan completed his Bachelor of Medicine and Bachelor of Surgery at the University of Western Australia and began his medical career at Royal Perth Hospital. He undertook specialist training in radiation oncology at Sir Charles Gairdner and Fiona Stanley Hospitals, followed by a clinical research fellowship at the Sunnybrook Odette Cancer Centre in Toronto, Canada, focusing on neuro-oncology, thoracic oncology, stereotactic ablative body radiotherapy (SABR), and MRI-guided radiotherapy.
Dr Tan led the clinical introduction of MRI-guided adaptive radiotherapy in Western Australia, pioneering the implementation of MR-Linac technology in patient care. He is an active member of the TROG CNS Working Group, the TROG Thoracic Working Group, and the TROG MR in Radiotherapy Special Interest Group. He is also a member of several leading cancer trial groups, including the American Society of Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO). He has delivered presentations at international and national meetings and authored multiple publications in reputable peer-reviewed journals, with a research focus on novel imaging, SABR, and treatment strategies to improve patient outcomes.
Dr Tan is deeply involved in teaching and education. He has served as a clinical oncology lecturer at UWA and a clinical examiner for radiation oncology trainees at the University of Toronto. He is currently a final-year medical student examiner at UWA and a Phase 1 examiner for radiation oncology trainees in Australia. His contributions to education were recognised with the “Excellence in Clinical Teaching Award by a Clinical Fellow” from the University of Toronto.
More information
Hendrick’s key clinical interests are in neuro-oncology (brain, skull base, spine), thoracic, oligometastases, upper gastrointestinal, skin and urological cancers. His current technical interests are in the field of SABR, stereotactic radiosurgery (SRS) and adaptive MRIgRT technology. He also has special interest in patient-reported outcomes and population databases.
- Royal Australian New Zealand College of Radiologists (RANZCR)
- American Society for Radiotherapy and Oncology (ASTRO)
- American Society of Clinical Oncology (ASCO)
- Canadian Association of Radiation Oncology (CARO)
- European Society for Radiotherapy and Oncology (ESTRO)
- Trans-Tasman Radiation Oncology Group (TROG)
- Radiosurgery Society (RSS)
- International Association for the Study of Lung Cancer (IASLC)
- Asia Pacific Radiation Oncology Special Interest Group (APROSIG)
- Tan, H., Sen, A., Picton, M., Tran, C., Batumalai, V., Bryne, H., Crawford, D., Twentyman, T., Jameson, M., Kasraei, F., Heinke, M., Jelen, U., Peng, V., Liang, T., Leong, E., Rahim, K., Lim, T., & de Leon, J. (2025). 3638 MRI guided dose escalated stereotactic prostate radiotherapy: Acute and long-term clinical outcomes of initial 100 patients. Radiotherapy and Oncology, 206(Suppl 1), S2061–S2062. https://doi.org/10.1016/S0167-8140(25)01852-3
- Tan, H., Stewart, J., Ruschin, M., Wang, M. H., Myrehaug, S., Tseng, C. L., ... & Soliman, H. (2022). Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study. Journal of Neuro-Oncology, 156(3), 569-577.
- Tan, H., Cheung, P., Louie, A. V., Myrehaug, S., Niglas, M., Atenafu, E. G., ... & Soliman, H. (2021). Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: treatment indication matters. Radiotherapy and Oncology, 161, 159-165.
- Tan, H., Nusrat, H., Li, G., Poon, I., Tsao, M., Ung, Y. C., ... & Louie, A. V. (2021). Safety and efficacy of stereotactic body radiotherapy for ultra-central thoracic tumors. International Journal of Radiation Oncology, Biology, Physics, 111(3), e453-e454.
- Li, G. J., Tan, H., Chen, H., Parmar, A., & Louie, A. V. (2021). Immunotherapy and Stereotactic Ablative Radiotherapy for Lung Cancer with Co-existing Interstitial Lung Disease: A Case Report. Clinical Lung Cancer, 22(5), e734-e737.
- Tan, H., Joseph, D., Loh, N. K., McCarthy, M., Leong, E., Siew, T., ... & Francis, R. J. (2016). A pilot study of the utility of choline PET–CT in prostate cancer biochemical relapse following radical prostatectomy. Journal of Medical Imaging and Radiation Oncology, 60(3), 374-381.
View a complete list of Dr Hendrick Tan's publications here.
